The MTI × OSP Advisors playbook
Why GPO & IDN Contracts Stall
For early-stage ortho, spine and biologics companies, contracting is the longest, least predictable step in market access. Clinical evidence alone rarely speeds it up. Most delays trace back to four gaps.
-
Wrong door
Pitching whoever answers, not the category manager or value analysis lead who owns the decision.
-
Wrong category
Submitting without knowing how contracts are classified, and landing in a crowded or ill-fitting category.
-
Weak positioning
No field-level view of how the product competes against incumbents already on contract.
-
Unreliable cross-reference
Contracting teams can’t map the product to existing spend, so the review stalls.
